Dublin Core PKP Metadata Items Metadata for this Document
 
1. Title Title of document Are you being managed?
 
2. Creator Author's name, affiliation, country Jonathan Jureidini; Adelaide, South Australia, AUSTRALIA.
 
3. Subject Discipline(s)
 
3. Subject Keyword(s)
 
4. Description Abstract There are at least 15 points of intervention by the pharmaceutical industry in the causal pathway from a TV ad to a prescription. Ghost-managed medicine exposes Big Pharma’s calculated control of this pathway. Many of the interventions might appear to come from outside industry with contributions from seemingly independent researchers, medical experts, regulators and consumer organisations. But it is all carefully and ruthlessly orchestrated by industry; egregious examples from the United States include the Orwellian “patient advocacy” group, Centre for Medicine in the Public Interest, created as a voice for Big Pharma and controlled by it.

 
5. Publisher Organizing agency, location Forum for Medical Ethics Society
 
6. Contributor Sponsor(s)
 
7. Date (YYYY-MM-DD) 2020-09-08
 
8. Type Status & genre
 
8. Type Type
 
9. Format File format HTML , PDF
 
10. Identifier Uniform Resource Identifier https://ijme.in/articles/are-you-being-managed/
 
11. Source Title; vol., no. (year) Indian Journal of Medical Ethics;: Theme‐Double Standards Redux: The Ethics of Future Covid‐19 Vaccine Research
 
12. Language English=en en
 
13. Relation Supp. Files
 
14. Coverage Geo-spatial location, chronological period, research sample (gender, age, etc.)
 
15. Rights Copyright and permissions

All articles published in IJME are available on its website free of charge. The copyright for published material belongs to IJME/FMES. IJME freely permits the reprint (or reproduction on a website) of articles from the journal, as long as this is for non-commercial use and appropriate credit is given to the author and the journal and publication details are mentioned. The commercial use of our content can be made only after obtaining permission from and on payment to IJME. This is intended to support production of the journal.